Terms: = Gastric cancer AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Treatment
2 results:
1. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
[TBL] [Abstract] [Full Text] [Related]
2. WNT2 and human gastrointestinal cancer (review).
Katoh M
Int J Mol Med; 2003 Nov; 12(5):811-6. PubMed ID: 14533014
[TBL] [Abstract] [Full Text] [Related]
